Gilead Sciences, Inc. (LON:0QYQ)
140.61
+3.64 (2.66%)
At close: Jan 27, 2026
47.35% (1Y)
| Market Cap | 125.85B |
| Revenue (ttm) | 21.64B +2.8% |
| Net Income | 6.03B +6,336.5% |
| EPS | 4.78 +6,514.1% |
| Shares Out | n/a |
| PE Ratio | 20.86 |
| Forward PE | 16.32 |
| Dividend | 2.36 (1.68%) |
| Ex-Dividend Date | Dec 15, 2025 |
| Volume | 6,048 |
| Average Volume | 4,909 |
| Open | 137.60 |
| Previous Close | 136.97 |
| Day's Range | 137.10 - 141.52 |
| 52-Week Range | 92.42 - 141.52 |
| Beta | 0.35 |
| RSI | 76.52 |
| Earnings Date | Feb 10, 2026 |